Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Evolus, Inc.(NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its first quarter 2021 financial results and provide a business update onWednesday, May 12, 2021, after the close of the U.S. financial markets.


GlobeNewswire Inc | May 4, 2021 04:05PM EDT

May 04, 2021

NEWPORT BEACH, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc.(NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its first quarter 2021 financial results and provide a business update onWednesday, May 12, 2021, after the close of the U.S. financial markets.

Management will host a conference call and live webcast to discuss Evolus financial results at4:30 p.m. ET that same day. A question and answer session will follow management remarks.

The dial-in numbers for the conference call are (866) 916-2317 for domestic callers and (703) 925-2662 for international callers. The conference ID is 7749489.

A replay of the call will be available following its completion through May 19, 2021. To access the replay, dial (855) 859-2056 for domestic callers and (404) 537-3406 for international callers and use the replay conference ID 7749489.

A live audio webcast of the call will be available on the Investor Relations page of theEvolus, Inc.website, https://investors.evolus.com. A replay of the webcast will be archived onEvolus'website for 30 days following the completion of the call.

AboutEvolus, Inc.

Evolusis a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, theU.S. Food and Drug Administrationapproved Jeuveau(prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure technology. Jeuveauis powered byEvolus'unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at: http://www.evolus.com.

Jeuveauis a registered trademark ofEvolus, Inc.

Hi-Pure is a trademark of Daewoong Pharmaceutical Co, Ltd.

Investor ContactThe Ruth GroupChristine PetragliaSenior Vice PresidentTel: 917-633-8980Email: cpetraglia@theruthgroup.com









Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC